Hypera Investor Relations Material
Latest events
Q1 2025
Hypera
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hypera S.A.
Access all reports
Hypera S.A. operates as a pharmaceutical company in Brazil. The company is involved in the production, research and development, marketing, sale and distribution of medicinal products for the treatment of various diseases such as diabetes, asthma, epilepsy and other disorders. Hypera S.A. engages through Pharmaceuticals and Biotechnologies segments. The Pharmaceuticals segment promotes and sells hyperbaric oxygen therapy (HOT) chambers to treat burns; Cortical Stimulation Therapy (CST); foot orthoses; jogging rollers; heart valves, pacemakers and implantable cardioverter defibrillator; the pregnancy test kit, pregnancy urine test kit and ovulation predictors; and iron supplements.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
HYPE3
Country
🇧🇷 Brazil